Patient Empowerment Network

Our mission is to fortify the health care consumer with the knowledge and tools to feel more confident playing a central role in decisions that affect their health, putting them more in control of their health and health care.

To especially empower patients and families dealing with cancer and serious, life-long chronic conditions so their “journey” can be better.

Contact information:

Seattle , WA


How Is the AML Treatment Landscape Evolving?

What’s happening in AML treatment research? Watch now to hear expert Dr. Thomas LeBlanc give an encouraging update on new approaches to AML treatment, genetic profiling and more.


How Do Doctors Use Information From MRD Testing in Myeloma?

How are minimal residual disease (MRD) test results used? Watch now to hear expert Dr. Elisabet Manasanch discuss FDA-approved methods for MRD testing, optimal timing and value of results in myeloma.


Coping With the Cost of AML Care: Anxiety From Financial Toxicity

How can people deal with financial toxicity from AML care? Watch as Dr. Thomas LeBlanc and Michelle Rajotte discuss financial barriers to AML treatment and resources to help patients find assistance.


Is There Maintenance Treatment After CAR T-Cell Therapy?

Is maintenance treatment necessary after success with CAR T-cell therapy? Watch as Dr. Elisabet Manasanch discusses research on treatment response and follow-up care.


How Can AML Patients Benefit From Support Groups?

Can support groups help patients and loved ones living with AML cope with anxiety, fear and depression? Listen as patient advocate Jim Bond shares tips for managing emotional distress.


Accessing Novel Treatments: Why Should Lung Cancer Patients Consider a Clinical Trial?

Why should lung cancer patients consider a clinical trial? Tune in to hear Dr. Lecia Sequist and Janet Freeman-Daily answer and share research highlights from a recent lung cancer conference.


Is Maintenance Therapy Necessary for MRD-Negative Myeloma Patients?

If a myeloma patient is declared MRD-negative, do they still need maintenance therapy indefinitely? Tune in as Dr. Elisabet Manasanch gives expert advice and explains current research on patients with MRD-negative status.


How Can Patients Combat the Cost of Sophisticated Blood Tests?

How can cancer patients access the necessary diagnostic and genetic tests to receive the most precise care available? Tune in to hear Dr. Richard Schilsky discuss typical insurance coverage and best use of genetic profiling.


Understanding M Protein Level and MRD Testing in Myeloma

What is a good M protein level range for myeloma patients? When is MRD testing recommended? Watch now to hear expert Dr. Elisabet Manasanch explain.


Showing 9 of 728 programs
tritt unserer Gemeinschaft bei Registrieren Sie sich für Veranstaltungen Lesen Sie unseren neuesten Blog

Page last updated on June 16, 2017